{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:03Z","timestamp":1770824283751,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:00:00Z","timestamp":1573862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s12022-019-09595-0","type":"journal-article","created":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T17:01:32Z","timestamp":1573923692000},"page":"276-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Loss of BAP1 in Pheochromocytomas and Paragangliomas Seems Unrelated to Genetic Mutations"],"prefix":"10.1007","volume":"30","author":[{"given":"Valeria","family":"Maffeis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocco","family":"Cappellesso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Nicol\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza","family":"Guzzardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Menin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Elefanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrogio","family":"Fassina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,16]]},"reference":[{"key":"9595_CR1","volume-title":"WHO Classification of tumours of endocrine organs","year":"2017","unstructured":"Lloyd RV, Osamura RY, Kl\u00f6ppel G, Rosai J (eds) (2017) WHO Classification of tumours of endocrine organs, 4th ed. IARC, Lyon, France","edition":"4"},{"key":"9595_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.critrevonc.2016.01.022","volume":"100","author":"S Pillai","year":"2016","unstructured":"Pillai S, Gopalan V, Smith RA, Lam AK-Y (2016) Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era. Crit Rev Oncol Hematol 100:190\u2013208. https:\/\/doi.org\/10.1016\/j.critrevonc.2016.01.022","journal-title":"Crit Rev Oncol Hematol"},{"key":"9595_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","volume":"31","author":"L Fishbein","year":"2017","unstructured":"Fishbein L, Leshchiner I, Walter V, Danilova L., Robertson A.G., Johnson A.R., Lichtenberg T.M., Murray B.A., Ghayee H.K., Else T., Ling S., Jefferys S.R., de Cubas A.A., Wenz B., Korpershoek E., Amelio A.L., Makowski L., Rathmell W.K., Gimenez-Roqueplo A.P., Giordano T.J., Asa S.L., Tischler A.S., Cancer Genome Atlas Research Network, Pacak K., Nathanson K.L., Wilkerson M.D. (2017) Comprehensive molecular characterization of pheochromocytoma and paraganglioma. Cancer Cell 31:181\u2013193. https:\/\/doi.org\/10.1016\/j.ccell.2017.01.001","journal-title":"Cancer Cell"},{"key":"9595_CR4","doi-asserted-by":"publisher","first-page":"25756","DOI":"10.18632\/oncotarget.15201","volume":"8","author":"SO Zhikrivetskaya","year":"2017","unstructured":"Zhikrivetskaya SO, Snezhkina AV, Zaretsky AR, Alekseev BY, Pokrovsky AV, Golovyuk AL, Melnikova NV, Stepanov OA, Kalinin DV, Moskalev AA, Krasnov GS, Dmitriev AA, Kudryavtseva AV (2017) Molecular markers of paragangliomas\/pheochromocytomas. Oncotarget 8:25756\u201325782. https:\/\/doi.org\/10.18632\/oncotarget.15201","journal-title":"Oncotarget"},{"key":"9595_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G (2013) BAP1 and cancer. Nat Rev Cancer 13:153\u2013159. https:\/\/doi.org\/10.1038\/nrc3459","journal-title":"Nat Rev Cancer"},{"key":"9595_CR6","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.1228463","volume":"337","author":"AE White","year":"2012","unstructured":"White AE, Harper JW (2012) Cancer. Emerging anatomy of the BAP1 tumor suppressor system. Science 337:1463\u20131464. https:\/\/doi.org\/10.1126\/science.1228463","journal-title":"Science"},{"key":"9595_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/1479-5876-10-179","volume":"10","author":"M Carbone","year":"2012","unstructured":"Carbone M, Ferris LK, Baumann F, Napolitano A, Lum CA, Flores EG, Gaudino G, Powers A, Bryant-Greenwood P, Krausz T, Hyjek E, Tate R, Friedberg J, Weigel T, Pass HI, Yang H (2012) BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 10:179. https:\/\/doi.org\/10.1186\/1479-5876-10-179","journal-title":"J Transl Med"},{"key":"9595_CR8","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1136\/jclinpath-2016-203866","volume":"69","author":"A Wang","year":"2016","unstructured":"Wang A, Papneja A, Hyrcza M, al-Habeeb A, Ghazarian D (2016) Gene of the month: BAP1. J Clin Pathol 69:750\u2013753. https:\/\/doi.org\/10.1136\/jclinpath-2016-203866","journal-title":"J Clin Pathol"},{"key":"9595_CR9","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1038\/ng.910","volume":"43","author":"T Wiesner","year":"2011","unstructured":"Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, R\u00fctten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR (2011) Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018\u20131021. https:\/\/doi.org\/10.1038\/ng.910","journal-title":"Nat Genet"},{"key":"9595_CR10","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1111\/pde.13553","volume":"35","author":"RE Watchorn","year":"2018","unstructured":"Watchorn RE, Calonje E, Taibjee SM (2018) Germline BRCA1-associated protein 1 mutation presenting as BAP1 inactivated melanocytic nevi in a child of a father with fatal paraganglioma. Pediatr Dermatol 35:e316\u2013e318. https:\/\/doi.org\/10.1111\/pde.13553","journal-title":"Pediatr Dermatol"},{"key":"9595_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/pcmr.12006","volume":"25","author":"K Wadt","year":"2012","unstructured":"Wadt K, Choi J, Chung J-Y, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, Brown KM (2012) A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res 25:815\u2013818. https:\/\/doi.org\/10.1111\/pcmr.12006","journal-title":"Pigment Cell Melanoma Res"},{"key":"9595_CR12","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pe\u00f1a-Llopis","year":"2012","unstructured":"Pe\u00f1a-Llopis S, Vega-Rub\u00edn-de-Celis S, Liao A, Leng N, Pav\u00eda-Jim\u00e9nez A, Wang S, Yamasaki T, Zhrebker L, Sivanand S, Spence P, Kinch L, Hambuch T, Jain S, Lotan Y, Margulis V, Sagalowsky AI, Summerour PB, Kabbani W, Wong SW, Grishin N, Laurent M, Xie XJ, Haudenschild CD, Ross MT, Bentley DR, Kapur P, Brugarolas J (2012) BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 44:751\u2013759. https:\/\/doi.org\/10.1038\/ng.2323","journal-title":"Nat Genet"},{"key":"9595_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/neuonc\/now235","volume":"19","author":"GM Shankar","year":"2017","unstructured":"Shankar GM, Abedalthagafi M, Vaubel RA, Merrill PH, Nayyar N, Gill CM, Brewster R, Bi WL, Agarwalla PK, Thorner AR, Reardon DA, al-Mefty O, Wen PY, Alexander BM, van Hummelen P, Batchelor TT, Ligon KL, Ligon AH, Meyerson M, Dunn IF, Beroukhim R, Louis DN, Perry A, Carter SL, Giannini C, Curry WT Jr, Cahill DP, Barker FG 2nd, Brastianos PK, Santagata S (2017) Germline and somatic BAP1 mutations in high-grade rhabdoid meningiomas. Neuro Oncology 19:535\u2013545. https:\/\/doi.org\/10.1093\/neuonc\/now235","journal-title":"Neuro Oncology"},{"key":"9595_CR14","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/ng.2813","volume":"45","author":"Y Jiao","year":"2013","unstructured":"Jiao Y, Pawlik TM, Anders RA, Selaru FM, Streppel MM, Lucas DJ, Niknafs N, Guthrie VB, Maitra A, Argani P, Offerhaus GJA, Roa JC, Roberts LR, Gores GJ, Popescu I, Alexandrescu ST, Dima S, Fassan M, Simbolo M, Mafficini A, Capelli P, Lawlor RT, Ruzzenente A, Guglielmi A, Tortora G, de Braud F, Scarpa A, Jarnagin W, Klimstra D, Karchin R, Velculescu VE, Hruban RH, Vogelstein B, Kinzler KW, Papadopoulos N, Wood LD (2013) Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 45:1470\u20131473. https:\/\/doi.org\/10.1038\/ng.2813","journal-title":"Nat Genet"},{"key":"9595_CR15","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/gcc.22381","volume":"55","author":"C Luchini","year":"2016","unstructured":"Luchini C, Veronese N, Yachida S, Cheng L, Nottegar A, Stubbs B, Solmi M, Capelli P, Pea A, Barbareschi M, Fassan M, Wood LD, Scarpa A (2016) Different prognostic roles of tumor suppressor gene BAP1 in cancer: a systematic review with meta-analysis. Genes Chromosomes Cancer 55:741\u2013749. https:\/\/doi.org\/10.1002\/gcc.22381","journal-title":"Genes Chromosomes Cancer"},{"key":"9595_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12920-018-0327-0","volume":"11","author":"AV Snezhkina","year":"2018","unstructured":"Snezhkina AV, Lukyanova EN, Kalinin DV, Pokrovsky AV, Dmitriev AA, Koroban NV, Pudova EA, Fedorova MS, Volchenko NN, Stepanov OA, Zhevelyuk EA, Kharitonov SL, Lipatova AV, Abramov IS, Golovyuk AV, Yegorov YE, Vishnyakova KS, Moskalev AA, Krasnov GS, Melnikova NV, Shcherbo DS, Kiseleva MV, Kaprin AD, Alekseev BY, Zaretsky AR, Kudryavtseva AV (2018) Exome analysis of carotid body tumor. BMC Med Genomics 11:17. https:\/\/doi.org\/10.1186\/s12920-018-0327-0","journal-title":"BMC Med Genomics"},{"key":"9595_CR17","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/jnci\/djy088","volume":"110","author":"W Sauerbrei","year":"2018","unstructured":"Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG (2018) Reporting recommendations for tumor marker prognostic studies (REMARK): an abridged explanation and elaboration. J Natl Cancer Inst 110:803\u2013811. https:\/\/doi.org\/10.1093\/jnci\/djy088","journal-title":"J Natl Cancer Inst"},{"key":"9595_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00428-018-2478-y","volume":"474","author":"S Sarcognato","year":"2019","unstructured":"Sarcognato S, Gringeri E, Fassan M, di Giunta M, Maffeis V, Guzzardo V, Cillo U, Guido M (2019) Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma. Virchows Arch 474:29\u201337. https:\/\/doi.org\/10.1007\/s00428-018-2478-y","journal-title":"Virchows Arch"},{"key":"9595_CR19","volume-title":"WHO classification of skin tumours","year":"2018","unstructured":"Elder DE, Massi D, Scolyer R, Willemze R (eds) (2018) WHO classification of skin tumours, 4th ed. IARC, Lyon, France","edition":"4"},{"key":"9595_CR20","unstructured":"cBioPortal (2019). https:\/\/www.cbioportal.org\/ Accessed 19 July 2019"},{"key":"9595_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1097\/PAT.0000000000000002","volume":"45","author":"AA Shah","year":"2013","unstructured":"Shah AA, Bourne TD, Murali R (2013) BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma. Pathology 45:651\u2013656. https:\/\/doi.org\/10.1097\/PAT.0000000000000002","journal-title":"Pathology"},{"key":"9595_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","volume":"27","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Verdijk RM, Brouwer RWW, van den Bosch T, van den Berg M, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van IJcken W, Kili\u00e7 E, de Klein A (2014) Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 27:1321\u20131330. https:\/\/doi.org\/10.1038\/modpathol.2014.43","journal-title":"Mod Pathol"},{"key":"9595_CR23","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/ng.912","volume":"43","author":"JR Testa","year":"2011","unstructured":"Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M (2011) Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022\u20131025. https:\/\/doi.org\/10.1038\/ng.912","journal-title":"Nat Genet"},{"key":"9595_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","volume":"10","author":"M Nasu","year":"2015","unstructured":"Nasu M, Emi M, Pastorino S, Tanji M, Powers A, Luk H, Baumann F, Zhang YA, Gazdar A, Kanodia S, Tiirikainen M, Flores E, Gaudino G, Becich MJ, Pass HI, Yang H, Carbone M (2015) High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma. J Thorac Oncol 10:565\u2013576. https:\/\/doi.org\/10.1097\/JTO.0000000000000471","journal-title":"J Thorac Oncol"},{"key":"9595_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","volume":"45","author":"R Murali","year":"2013","unstructured":"Murali R, Wiesner T, Scolyer RA (2013) Tumours associated with BAP1 mutations. Pathology 45:116\u2013126. https:\/\/doi.org\/10.1097\/PAT.0b013e32835d0efb","journal-title":"Pathology"},{"key":"9595_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","volume":"48","author":"MH Abdel-Rahman","year":"2011","unstructured":"Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH (2011) Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856\u2013859. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100156","journal-title":"J Med Genet"},{"key":"9595_CR27","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","volume":"76","author":"Y Kadariya","year":"2016","unstructured":"Kadariya Y, Cheung M, Xu J, Pei J, Sementino E, Menges CW, Cai KQ, Rauscher FJ, Klein-Szanto AJ, Testa JR (2016) Bap1 is a bona fide tumor suppressor: genetic evidence from mouse models carrying heterozygous germline Bap1 mutations. Cancer Res 76:2836\u20132844. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3371","journal-title":"Cancer Res"},{"key":"9595_CR28","doi-asserted-by":"publisher","first-page":"29080","DOI":"10.18632\/oncotarget.16175","volume":"8","author":"H Song","year":"2017","unstructured":"Song H, Wang L, Lyu J, Wu Y, Guo W, Ren G (2017) Loss of nuclear BAP1 expression is associated with poor prognosis in oral mucosal melanoma. Oncotarget 8:29080\u201329090. https:\/\/doi.org\/10.18632\/oncotarget.16175","journal-title":"Oncotarget"},{"key":"9595_CR29","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-14-2854","volume":"21","author":"J Crona","year":"2015","unstructured":"Crona J, Backman S, Maharjan R, Mayrhofer M, St\u00e5lberg P, Isaksson A, Hellman P, Bj\u00f6rklund P (2015) Spatiotemporal heterogeneity characterizes the genetic landscape of pheochromocytoma and defines early events in tumorigenesis. Clin Cancer Res 21:4451\u20134460. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2854","journal-title":"Clin Cancer Res"},{"key":"9595_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/cjp2.86","volume":"4","author":"N Farquhar","year":"2018","unstructured":"Farquhar N, Thornton S, Coupland SE, Coulson JM, Sacco JJ, Krishna Y, Heimann H, Taktak A, Cebulla CM, Abdel-Rahman MH, Kalirai H (2018) Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma. J Pathol Clin Res 4:26\u201338. https:\/\/doi.org\/10.1002\/cjp2.86","journal-title":"J Pathol Clin Res"},{"key":"9595_CR31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1186\/s12885-018-5079-x","volume":"18","author":"KG Ewens","year":"2018","unstructured":"Ewens KG, Lalonde E, Richards-Yutz J, Shields CL, Ganguly A (2018) Comparison of germline versus somatic BAP1 mutations for risk of metastasis in uveal melanoma. BMC Cancer 18:1172. https:\/\/doi.org\/10.1186\/s12885-018-5079-x, 1112","journal-title":"BMC Cancer"},{"key":"9595_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cancergen.2016.07.002","volume":"209","author":"V Ascoli","year":"2016","unstructured":"Ascoli V, Cozzi I, Vatrano S, Izzo S, Giorcelli J, Romeo E, Carnovale-Scalzo C, Grillo LR, Facciolo F, Visca P, Papotti M, Righi L (2016) Mesothelioma families without inheritance of a BAP1 predisposing mutation. Cancer Genet 209:381\u2013387. https:\/\/doi.org\/10.1016\/j.cancergen.2016.07.002","journal-title":"Cancer Genet"},{"key":"9595_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206643","volume":"13","author":"T Hirosawa","year":"2018","unstructured":"Hirosawa T, Ishida M, Ishii K, Kanehara K, Kudo K, Ohnuma S, Kamei T, Motoi F, Naitoh T, Selaru FM, Unno M (2018) Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer. PLoS ONE 13:e0206643. https:\/\/doi.org\/10.1371\/journal.pone.0206643","journal-title":"PLoS ONE"},{"key":"9595_CR34","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","volume":"40","author":"JAP van de Nes","year":"2016","unstructured":"van de Nes JAP, Nelles J, Kreis S, Metz CH, Hager T, Lohmann DR, Zeschnigk M (2016) Comparing the prognostic value of BAP1 mutation pattern, chromosome 3 status, and BAP1 immunohistochemistry in uveal melanoma. Am J Surg Pathol 40:796\u2013805. https:\/\/doi.org\/10.1097\/PAS.0000000000000645","journal-title":"Am J Surg Pathol"},{"key":"9595_CR35","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","volume":"99","author":"B Royer-Bertrand","year":"2016","unstructured":"Royer-Bertrand B, Torsello M, Rimoldi D, el Zaoui I., Cisarova K., Pescini-Gobert R., Raynaud F., Zografos L., Schalenbourg A., Speiser D., Nicolas M., Vallat L., Klein R., Leyvraz S., Ciriello G., Riggi N., Moulin A.P., Rivolta C. (2016) Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing. Am J Hum Genet 99:1190\u20131198. https:\/\/doi.org\/10.1016\/j.ajhg.2016.09.008","journal-title":"Am J Hum Genet"},{"key":"9595_CR36","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.molcel.2014.03.002","volume":"54","author":"N Mashtalir","year":"2014","unstructured":"Mashtalir N, Daou S, Barbour H, Sen NN, Gagnon J, Hammond-Martel I, Dar HH, Therrien M, Affar el B (2014) Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol Cell 54:392\u2013406. https:\/\/doi.org\/10.1016\/j.molcel.2014.03.002","journal-title":"Mol Cell"},{"key":"9595_CR37","doi-asserted-by":"publisher","first-page":"486","DOI":"10.4161\/epi.24552","volume":"8","author":"I Ibragimova","year":"2013","unstructured":"Ibragimova I, Maradeo ME, Dulaimi E, Cairns P (2013) Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC. Epigenetics 8:486\u2013493. https:\/\/doi.org\/10.4161\/epi.24552","journal-title":"Epigenetics"},{"key":"9595_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/376423","volume":"2015","author":"\u00c9rica S. S. de Ara\u00fajo","year":"2015","unstructured":"de Ara\u00fajo \u00c9SS, Pramio DT, Kashiwabara AY, et al. (2015) DNA Methylation levels of melanoma risk genes are associated with clinical characteristics of melanoma patients. Biomed Res Int 2015:. https:\/\/doi.org\/10.1155\/2015\/376423","journal-title":"BioMed Research International"},{"issue":"18","key":"9595_CR39","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1158\/1078-0432.CCR-19-0366","volume":"25","author":"Matthew G. Field","year":"2019","unstructured":"Field MG, Kuznetsov JN, Bussies PL, et al. (2019) BAP1 loss is associated with DNA methylomic repatterning in highly aggressive Class 2 uveal melanomas. Clin Cancer Res https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0366","journal-title":"Clinical Cancer Research"},{"issue":"9","key":"9595_CR40","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/cup.13488","volume":"46","author":"Amin A. Hedayat","year":"2019","unstructured":"Hedayat AA, Lefferts JA, Atkinson AE, et al. (2019) BAP1-deficient tumor\/nevus with germline aberration: a potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array. J Cutan Pathol https:\/\/doi.org\/10.1111\/cup.13488","journal-title":"Journal of Cutaneous Pathology"},{"key":"9595_CR41","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.7150\/jca.20234","volume":"8","author":"Y-Z Ge","year":"2017","unstructured":"Ge Y-Z, Xu L-W, Zhou C-C, Lu TZ, Yao WT, Wu R, Zhao YC, Xu X, Hu ZK, Wang M, Yang XB, Zhou LH, Zhong B, Xu Z, Li WC, Zhu JG, Jia RP (2017) A BAP1 Mutation-specific microRNA signature predicts clinical outcomes in clear cell renal cell carcinoma patients with wild-type BAP1. J Cancer 8:2643\u20132652. https:\/\/doi.org\/10.7150\/jca.20234","journal-title":"J Cancer"},{"key":"9595_CR42","doi-asserted-by":"publisher","first-page":"6044","DOI":"10.1038\/ncomms7044","volume":"6","author":"LJ Castro-Vega","year":"2015","unstructured":"Castro-Vega LJ, Letouz\u00e9 E, Burnichon N, Buffet A, Disderot PH, Khalifa E, Loriot C, Elarouci N, Morin A, Menara M, Lepoutre-Lussey C, Badoual C, Sibony M, Dousset B, Lib\u00e9 R, Zinzindohoue F, Plouin PF, Bertherat J, Amar L, de Reyni\u00e8s A, Favier J, Gimenez-Roqueplo AP (2015) Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas. Nat Commun 6:6044. https:\/\/doi.org\/10.1038\/ncomms7044","journal-title":"Nat Commun"},{"key":"9595_CR43","doi-asserted-by":"publisher","first-page":"13742","DOI":"10.18632\/oncotarget.7328","volume":"7","author":"M Yu","year":"2016","unstructured":"Yu M, Liang H, Fu Z, Wang X, Liao Z, Zhou Y, Liu Y, Wang Y, Hong Y, Zhou X, Yan X, Yu M, Ma M, Zhang W, Guo B, Zhang J, Zen K, Zhang CY, Wang T, Zhang Q, Chen X (2016) BAP1 suppresses lung cancer progression and is inhibited by miR-31. Oncotarget 7:13742\u201313753. https:\/\/doi.org\/10.18632\/oncotarget.7328","journal-title":"Oncotarget"},{"key":"9595_CR44","doi-asserted-by":"publisher","first-page":"101042831769911","DOI":"10.1177\/1010428317699111","volume":"39","author":"X-Y Wang","year":"2017","unstructured":"Wang X-Y, Wang Z, Huang J-B, Ren XD, Ye D, Zhu WW, Qin LX (2017) Tissue-specific significance of BAP1 gene mutation in prognostic prediction and molecular taxonomy among different types of cancer. Tumour Biol 39:1010428317699111. https:\/\/doi.org\/10.1177\/1010428317699111","journal-title":"Tumour Biol"},{"key":"9595_CR45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","volume":"28","author":"M Cigognetti","year":"2015","unstructured":"Cigognetti M, Lonardi S, Fisogni S, Balzarini P, Pellegrini V, Tironi A, Bercich L, Bugatti M, Rossi G, Murer B, Barbareschi M, Giuliani S, Cavazza A, Marchetti G, Vermi W, Facchetti F (2015) BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol 28:1043\u20131057. https:\/\/doi.org\/10.1038\/modpathol.2015.65","journal-title":"Mod Pathol"},{"key":"9595_CR46","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1093\/jnci\/djy171","volume":"110","author":"S Walpole","year":"2018","unstructured":"Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardi\u00e8re A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, J\u00e4rvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, H\u00f6iom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivel\u00e4 TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK (2018) Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide. J Natl Cancer Inst 110:1328\u20131341. https:\/\/doi.org\/10.1093\/jnci\/djy171","journal-title":"J Natl Cancer Inst"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-09595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-019-09595-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-019-09595-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:25:53Z","timestamp":1605399953000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-019-09595-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,16]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9595"],"URL":"https:\/\/doi.org\/10.1007\/s12022-019-09595-0","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,16]]},"assertion":[{"value":"16 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}